Importer of Controlled Substances Application: Akorn, Inc., 44918 [2019-18453]
Download as PDF
<![CDATA[
44918
Federal Register / Vol. 84, No. 166 / Tuesday, August 27, 2019 / Notices
In accordance with 21 CFR
1301.33(a), this is notice that on July 17,
2019, Nanosyn Inc., 3331 Industrial
Drive, Suite B, Santa Rosa, California
95403–2062 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled Substance
Fentanyl .........................
Oxymorphone ................
Drug
Code
9801
9652
Schedule
II
II
The company is a contract
manufacturer. At the request of the
company’s customers, it manufactures
derivatives of controlled substances in
bulk form.
Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 7, 2019, Akorn
Inc., 1222 West Grand Avenue Decatur,
Illinois 62522–1412 applied to be
registered as an importer of the
following basic class of controlled
substance:
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–18454 Filed 8–26–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Controlled
substance
[Docket No. DEA–392]
Remifentanil ..................
Importer of Controlled Substances
Application: Akorn, Inc.
ACTION:
9739
Schedule
II
The company plans to import the
above listed controlled substance for
research purposes.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 26, 2019. Such
persons may also file a written request
for a hearing on the application on or
before September 26, 2019.
DATES:
Drug
code
Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019–18453 Filed 8–26–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cerilliant Corporation
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 26, 2019. Such
persons may also file a written request
for a hearing on the application on or
before September 26, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 9, 2019, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402 applied
to be registered as an importer of the
following basic classes of controlled
substances:
DATES:
Drug
code
jspears on DSK3GMQ082PROD with NOTICES
Controlled substance
3-Fluoro-N-methylcathinone (3-FMC) ..........................................................................................................................................
Cathinone ....................................................................................................................................................................................
Methcathinone .............................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ..........................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...............................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ................................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ............................................................................................................................................
Naphyrone ...................................................................................................................................................................................
N-Ethylamphetamine ...................................................................................................................................................................
N,N-Dimethylamphetamine ..........................................................................................................................................................
Fenethylline .................................................................................................................................................................................
Methaqualone ..............................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...............................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .............................................................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .............................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................................
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .............................................................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............................
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..............................................
VerDate Sep<11>2014
19:12 Aug 26, 2019
Jkt 247001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
E:\FR\FM\27AUN1.SGM
27AUN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
2565
6250
7008
7011
7012
7019
7023
7024
7031
7035
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 84, Number 166 (Tuesday, August 27, 2019)]
[Notices]
[Page 44918]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18453]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Akorn, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before September 26, 2019.
Such persons may also file a written request for a hearing on the
application on or before September 26, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 7, 2019, Akorn Inc., 1222 West Grand Avenue
Decatur, Illinois 62522-1412 applied to be registered as an importer of
the following basic class of controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Remifentanil........................... 9739 II
------------------------------------------------------------------------
The company plans to import the above listed controlled substance
for research purposes.
Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18453 Filed 8-26-19; 8:45 am]
BILLING CODE 4410-09-P
